Home
Latest
Finance
IPO
ETF
Tech
Overseas
Video
Research
简
繁
EN
简
繁
EN
Home
Latest
Finance
IPO
ETF
Tech
Overseas
Video
Research
HOME
·
CSOP CSI 300 Index Daily (2x) Leveraged Product
CSOP CSI 300 Index Daily (2x) Leveraged Product(07233.HK): Intraday Rise of 1.37%, Net Asset Value per Unit at HK$5.49
Tags:
CSOP CSI 300 Index Daily (2x) Leveraged Product
07233.HK
ETF
2026-06-30
CSOP CSI 300 Index Daily (2x) Leveraged Product(07233.HK) Rises 0.37% Intraday, Net Asset Value Per Unit at HK$5.495
Tags:
CSOP CSI 300 Index Daily (2x) Leveraged Product
07233.HK
ETF
2026-06-24
CSOP CSI 300 Index Daily (2x) Leveraged Product(07233.HK) Rises 0.18% in Morning Session at HK$5.580
Tags:
CSOP CSI 300 Index Daily (2x) Leveraged Product
07233.HK
ETF
2026-06-22
CSOP CSI 300 Index Daily (2x) Leveraged Product(07233.HK) Rises 1.68% Intraday, NAV at HK$5.068
Tags:
CSOP CSI 300 Index Daily (2x) Leveraged Product
07233.HK
ETF
2026-06-09
Featured News
Research
HK Stock Connect Daily Report: SHANDONG MOLONG Rises 16.10% as Brent Crude Tops USD 103 - 20261008
Finance
SSY GROUP (02005.HK): Nimodipine oral solution wins production nod
Research
Hong Kong AI Concept Stock Daily: MINIMAX-W Slumps 13.74% as Dalio Warns the AI Bubble Is Near Its Breaking Point - 20261008
Finance
TAT HONG EQUIP (02153.HK): Issues 11th digital paper series
Finance
GIGADEVICE (03986.HK): September buyback reaches 789,600 shares
Finance
SBP GROUP (01177.HK): TQC3721 Phase III completes enrolment
Finance
NewTimeSpace | Hong Kong Market Close: The Three Major Indices Fluctuated and Weakened, with the Hang Seng Index Closing Down 1.43%, While Themes Such as Coal, Oil and Petrochemicals Strengthened Against the Trend
Research
Hong Kong Recently Listed Stocks Daily Report: ROKAE ROBOTICS Leads with 9.51% Gain, MINIMAX-W Tops Turnover at HKD 3.128 Billion - 20261008
Research
NewTimeSpace | A Roundup of "First Stocks" in Hong Kong IPOs (September 2026)
Research
HK Recently Listed Stocks Watch | IMPACT THERAP-B (07630.HK) down 9.59%, 13.93 million cornerstone shares to be unblocked on 13 November, ALLIST's furmonertinib misses Phase III primary endpoint
Scan QR Code
Download App